IPO - RedHill Biopharma Ltd.

Form Type: F-1

Filing Date: 2025-06-25

Corporate Action: Ipo

Type: New

Accession Number: 000117891325002235

Filing Summary: RedHill Biopharma Ltd. filed a new registration statement with the SEC for the resale of 5,596,490 American Depositary Shares (ADSs), each representing 10,000 ordinary shares. These ADSs are being offered by Alumni Capital LP, who will sell the shares from time to time at prevailing market prices. The Any Market Purchase Agreement allows RedHill to issue and sell ADSs to Alumni for an aggregate amount of up to $10 million, with the price determined based on the volume-weighted average price of the ADSs on the market. RedHill will not receive proceeds from this offering but will use any funds from exercised warrants for general corporate purposes. The company is therefore officially engaging in an IPO process, with the potential to raise significant funds depending on market conditions. The securities will be listed on Nasdaq under the symbol 'RDHL.'